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Veno-Venous Extracorporeal Membrane Oxygenation (V-V ECMO) is a treatment 
reserved for severely hypoxic patients despite optimal treatment with 
mechanical ventilation (MV). The role of V-V ECMO continues to evolve and 
is currently being utilized in patients with respiratory failure from influenza 
A (H1N1) who have failed conventional MV. Here we describe a cohort of 
patients requiring V-V ECMO for H1N1 induced severe adult respiratory distress 
syndrome (ARDS) compared to those with ARDS from other causes. Our goal is 
to report the differences in intensive care unit (ICU) length of stay (LOS), hospital 
LOS, length of time on ECMO and mortality in patients with H1N1 on ECMO 
compared to patients on ECMO due to alternative diseases. 
Methods
This is a single center descriptive study performed at the Lehigh Valley Health 
Network in Allentown, PA. Patients with severe ARDS requiring V-V ECMO 
between January 1, 2013 and March 31, 2014 were included. The institutional 
review board approved the study. The main outcomes were mortality, ICU LOS 





We have observed that patients on V-V ECMO for H1N1 have a longer hospital 
and ICU LOS and longer time on ECMO than patients on V-V ECMO for 
reasons other than H1N1. However, these patients have similar survival rates 
compared to the non-H1N1 ECMO patients. Therefore, when ECMO is used as 
a treatment for H1N1 patients, therapeutic nihilism must be avoided as these 
patients may still survive despite increased time on ECMO, increased LOS in 
the ICU and increased LOS in the hospital. 
Results
Thirty-six patients were included and 15 tested positive for H1N1. Median age 
was 50 years old and 16 were male. Overall ICU LOS was 29 days and survival 
to discharge was 72%. Patients undergoing V-V ECMO for H1N1 had a longer 
hospital LOS compared to those without Influenza (43.9 vs. 27.0 days) and 
longer ICU LOS (41.6 vs. 20.4 days) and longer time on ECMO (19.3 vs. 11.0 
days). Survival to hospital discharge was 80% in patients with H1N1 vs. 67% 
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